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Abstract: Primary illness with cytomegalovirus leads to latent infection with possible reactivations 
especially in the immunocompromised patients. Toxic epidermal necrolysis is an immune mediated 
cytotoxic reaction. 
A fifty years old female diabetic hypertensive patient with end stage renal disease was admitted 
with fever of unknown origin, constitutional symptoms, vague upper gastrointestinal symptoms and 
skin rash. Upper gastrointestinal endoscopic biopsy confirmed her diagnosis with cytomegalovirus 
esophagitis  and  duodenitis.  Cytomegalovirus  immunoglobulin  M  and  immunoglobulin  G  levels 
were negative but polymerase chain reaction showed fulminant viremia. Biopsy of the skin rash 
was consistent with toxic epidermal necrolysis. Despite treatment with Ganciclovir, intravenous 
immunoglobulins,  and  granulocyte  colony  stimulating  factor  the  patient’s  condition  rapidly 
deteriorated and she died due to multiorgan failure, disseminated intravascular coagulopathy and 
overwhelming sepsis. 
Probably there is a true association linking toxic epidermal necrolysis to fulminant reactivation of 
cytomegalovirus.  The  aim  of  this  anecdote  is  reporting  a  newly  recognized  presentation  of 
cytomegalovirus. 
 
Introduction:  Primary  illness  with  cytomegalovirus 
(CMV)  leads  to  latent  infection  with  possible 
reactivations  especially  in  the  immunocompromised 
patients. Both the primary illness and the reactivations 
are active CMV infections with viral replication.
1 
Toxic  epidermal  necrolysis  (TEN)  is  an  immune 
mediated  cytotoxic  destruction  of  keratinocytes  that 
express  foreign  antigens.  Most  commonly  it  is  drug 
induced  but  it  may  occur  secondary  to  infections, 
malignancies,  and  vaccinations.  It  mimics  type  IV Mediterr J Hematol Infect Dis 2011; 3; Open Journal System   
 
hypersensitivity  reaction  with  characteristic  delayed 
reaction to an initial exposure and an increasingly rapid 
reaction with repeated exposure.
2 The estimated annual 
incidence of TEN is reported to be between 0.4 and 1.3 
cases per million per year and may occur in all age 
groups. Reported mortality varies from 30 to 50% with 
the  primary  cause  of  death  being  infection  and 
multiorgan failure.
3 
The incidence of TEN increased to a thousand fold 
in patients with Human Immunodeficiency Virus and 
Acquired Immunodeficiency Syndrome.
4 This is due to 
an  imbalance  in  the  inherent  activation  and 
detoxification mechanisms as well as an altered innate 
immune  response.  Specific  viral  infections  had  been 
shown  to  increase  CD95  (Fas)  and/or  Fas  Ligand 
expression and increased sensitivity to Fas/Fas Ligand 
dependent apoptosis.
5 Authors have hypothesized that 
reactivation of human herpesvirus type 6 may seriously 
interact  with  some  of  the  enzymes  that  detoxify  the 
drugs,  such  as  cytochrome  P450.  The  toxic  and 
immunogenic metabolites of these drugs are deposited 
in  the  epidermis  leading  to  a  series  of  immune 
reactions causing TEN.
6 
 
Case report: A fifty years old caucasian female patient 
with  positive  family  history  for  hypertension  and 
negative  family  history  for  malignancy,  having 
hypertension controlled by lisinopril, amlodipine and 
bisoprolol fumarate, Diabetes mellitus type II (DM II) 
controlled by short acting regular insulin, and end stage 
renal disease (ESRD) on regular hemodialysis. She was 
admitted to the intensive care unit (ICU) with fever of 
unknown  origin  (FUO)  of  fourteen  days  duration 
associated with agitation, irritability, tachycardia (120 
beats  /  minute),  generalized  weakness,  anorexia, 
nausea,  vomiting,  diarrhea,  scratch  marks  and 
maculopapular rash (Figures 1 and 2). Sepsis workup 
was  done  followed  by  infusion  of  empirical 
intravenous broad spectrum antibiotics with the dose 
adjusted  according  to  renal  function  and  systemic 
steroids  were  started  with  methyl  prednisolone  40 
milligrams intravenous infusion once daily. 
On  Day  two,  the  patient  developed  severe  upper 
epigastric  pain.  Upper  gastrointestinal  endoscopic 
biopsy  confirmed  her  diagnosis  with  severe  CMV 
esophagitis and duodenitis. Treatment was started with 
intravenous  Ganciclovir  at  a  dose  of  1.25 
milligrams/kilogram  administered  three  times/week 
following each hemodialysis session.  
On day three the maculopapular rash progressed to 
erythroderma,  followed  by  development  of  bullous 
lesions all over the body associated with skin peeling, 
bleeding,  positive  Nikolsky’s  sign  and  mucous 
membrane involvement (Figures 3). Skin biopsy was 
done  and  the  pathology  showed  extensive epidermal 
 
Figure  1:  Illustration  shows  erythroderma  and  scaly  skin  of  the 
upper extremity. 
 
necrosis,  focal  subepidermal  necrotic  blisters  and 
extensive  vacuolar  degeneration  of  dermoepidermal 
junction  with  separation  of  the  epidermis  from  the 
dermis. The dermis showed melanin incontinence and 
moderate  perivascular  lymphocytic  infiltrate  in  the 
 
Figure  2:  Illustration  shows  erythroderma  and  scaly  skin  of  the 
trunk. Mediterr J Hematol Infect Dis 2011; 3; Open Journal System   
 
 
Figure 3. Illustration shows bullous lesions of the lower extremities 
associated with skin peeling, bleeding and positive Nikolsky’s sign. 
 
absence of eosinophils, neutrophils and viral inclusions 
(Figure  4).  TEN  was  confirmed.  All  the 
immunoflourescence  markers  that  were  done  on  the 
skin biopsy showed negative staining with nonspecific 
granular  deposition  in  the  necrotic  epidermis.  The 
immunoflourescence  markers  included 
Immunoglobulin  G  (IgG),  Immunoglobulin  A  (IgA), 
Immunoglobulin M (IgM) and Complement factor 3. 
On  day  15,  she  developed  pneumonia  which  was 
complicated  by  respiratory  failure.  Intubation  and 
mechanical  ventilation  were  initiated. 
 
 
Figure 4. Histopathological examination of the skin biopsy. The 
black  arrows  illustrate  the  pan  epidermal  necrosis  and  the  red 
arrows demonstrate the separation of the epidermis from the dermis 
On day 48 the patient, whose SCORTEN (severity-
of-illness score) was five and expected mortality rate 
was  90%,  passed  away  due  to  overwhelming  sepsis, 
shock and multiorgan failure. 
 
Discussion:  The  case  presented  showed  suggestive 
evidence  linking  CMV  to  TEN.  To  associate  CMV 
with TEN, we had to differentiate TEN from similar 
skin  diseases,  explore  other  possible  causes  of  TEN 
and  reactivation  of  CMV,  assess  the  temporal 
relationship  and  biological  plausibility,  show 
recognized association with the herpes viruses group 
and identify CMV. 
1.  Differentiate  TEN  from  similar  skin  diseases: 
Differential  diagnosis  included  Staphylococcal 
Scalded  Skin  Syndrome  (SSSS),  Toxic  Shock 
Syndrome,  Pemphigus  Vulgaris,  Bullous 
Pemphegoid  and  Bullous  Dermatosis  of 
hemodialysis.  Skin  biopsy  in  SSSS  and  Toxic 
Shock Syndrome shows superficial intra epidermal 
bullous  formation  but  in  TEN  there  is  pan-
epidermal  necrosis  with  subepidermal  bullous 
formation.  Treatment  of  SSSS  and  Toxic  Shock 
Syndrome  includes  antibiotics,  but  in  TEN  the 
antibiotics  may  cause  the  disease.
7  Pemphigus 
Vulgaris,  Bullous  Pemphegoid  and  Bullous 
Dermatosis of hemodialysis are usually self limited 
and occur on the photo-exposed parts but TEN is a 
rare, potentially life-threatening medical emergency 
characterized  by  wide-spread  epidermal  sloughing 
of  skin  accompanied  by  mucus  membrane 
involvement.
8 
2.  Exploring  other  possible  causes  of  TEN  and 
reactivation  of  CMV:  Etiology  of  TEN  includes 
drugs,  malignancies  and  infections  especially  in 
immunocompromised  patients  with  multiple 
comorbidities. Apart from her regular medications, 
there was no history of recent new drug or herbal 
ingestion.  Her  regular  medications  (lisinopril, 
amlodipine,  bisoprolol  fumarate  and  short  acting 
regular insulin) are not reported to cause Stevens-
Johnson syndrome or TEN. Furthermore, the patient 
had  used  her  regular  medications  for  many  years 
without  developing  this  severe  skin  disease.  The 
patient  had  negative  history  of  malignancy. 
Multiple chronic diseases and comorbidities as long 
standing  DM  II,  hypertension,  and  ESRD,  in 
addition to regular hemodialysis, systemic steroids, 
prolonged  ICU  stay  and  sepsis  kept  her  in  an 
immunocompromised state which increased the risk 
for reactivation of CMV, augmentation of the viral 
load and the virulence of CMV, and development of 
TEN. 
3.  Temporal  relationship  and  biological  plausibility: 
In  TEN  the  clinical  features  typically  include  a Mediterr J Hematol Infect Dis 2011; 3; Open Journal System   
 
prodrome  of  2  to  3  days  characterized  by  fever, 
cough, sore throat, and general malaise before the 
cutaneous manifestations of TEN become apparent. 
Symptoms  of  CMV  infection  in 
immunocompromised patients cover a broad range, 
from direct manifestations of viral replication like 
fever,  leucopenia,  thrombocytopenia,  hepatitis, 
enteritis, and pneumonia to indirect sequelae like an 
impaired  cellular  immune  response.  It  is  possible 
that  the  fourteen  days  FUO  that  the  patient 
experienced  before  ICU  admission  represent 
reactivation  of  CMV  with  viral  replication  that 
predisposed to TEN when the patient was admitted 
to ICU and started receiving empirical intravenous 
antibiotics.
9 
4.  Recognized  association  with  the  herpes  viruses 
group:  Cytomegalovirus  (human  herpesvirus  type 
5)  is  a  herpes  viral  genus  of  the  herpesviruses 
group.  High  rate  of  skin  reactions  to  ampicillin 
(80% to 100%) was noticed in patients with acute 
Epstein-Barr  virus  (human  herpesvirus  type  4). 
Reactivation of human herpesvirus type 6 has been 
reported  in  drug  induced  hypersensitivity 
syndrome.
10 
5.  Identification of CMV: Despite negative CMV IgG 
level of 15 grams / liter (reference range: 7-16) and 
IgM level of 0.531 grams / liter (reference range: 
0.4-2.3), yet CMV polymerase chain reaction (PCR) 
was  conclusive  of  fulminant  viremia  at  680,876 
copies / milliliter (Threshold: 350). 
 
Conclusions:  Patients  involved  are  only  one  (single 
case report). Cause implicated is CMV. Probably there 
is a true association linking CMV to TEN. Suggestive 
reasons  are  the  temporal  relationship  and  biological 
plausibility,  recognition  of  the  association  with  the 
herpes  viruses  group,  identification  of  CMV  and  all 
other possible causes of TEN were ruled out. 
The hypothesis generated is whether TEN is linked 
to  fulminant  CMV  infection  or  not  and  does  CMV 
trigger  an  interaction  between  cytotoxic  T-
lymphocytes, natural killer cells and keratinocytes or 
not. Further observational studies are warranted. 
Implications for clinical practice include: 
a)  Screening for CMV with PCR as a causative agent 
for TEN even in the absence of a clear history of 
offending drug ingestion and even if CMV IgM and 
IgG levels are negative. 
b) Systemic steroids are absolutely contraindicated in 
the treatment of TEN in case the causative agent is 
fulminant viral infection. 
Treatment strategies for TEN associated with CMV 
include  treatment  of  the  cause  with  Ganciclovir, 
avoidance of possible offending drugs associated with 
TEN and avoidance of systemic steroids assuming that 
most likely the underlying mechanism is interaction of 
CMV  with  some  of  the  enzymes  that  detoxify  the 
offending  drugs  associated  with  TEN  causing  the 
deposition of the toxic and immunogenic metabolites 
of these drugs in the epidermis leading to a series of 
immune reactions that end in TEN. 
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